DiaGenic Appoints Acting CEO

Lars Christian Stugaard has been appointed as acting CEO of DiaGenic on an interim basis effective from April 1 2014. Stugaard holds the position as CEO in Strata Marine & Offshore and has worked in the Ferncliff group since 2003. During his 11-year tenure with Ferncliff, he has been working with financial management, general business development and analysis.

DiaGenic is a Norwegian diagnostic company that develops in vitro diagnostic (IVD) products for early detection of diseases. DiaGenic claims to be a world leader in identifying gene expression signatures in blood and is focused on the development of IVD biomarker products in the field of Alzheimer's disease.

Lars Christian Stugaard has been appointed as acting CEO of DiaGenic on an interim basis effective from April 1 2014. Stugaard holds the position as CEO in Strata Marine & Offshore and has worked in the Ferncliff group since 2003. During his 11-year tenure with Ferncliff, he has been working with financial management, general business development and analysis.

DiaGenic is a Norwegian diagnostic company that develops in vitro diagnostic (IVD) products for early detection of diseases. DiaGenic claims to be a world leader in identifying gene expression signatures in blood and is focused on the development of IVD biomarker products in the field of Alzheimer's disease.

This article is tagged to:
Related sectors of this article: Medical Devices, Laboratory Diagnostics, Diagnostics
Geography: Norway
×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.